Brief: Lianbio Announces Marketing Approval Of Camzyos® (Mavacamten) In Singapore
26/06/2023 13:29
June 26 (Reuters) - LianBio LIAN.O :
* LIANBIO ANNOUNCES MARKETING APPROVAL OF CAMZYOS®
(MAVACAMTEN) IN
SINGAPORE
* LIANBIO - MARKETING APPROVAL IN SINGAPORE WAS BASED ON
DATA FROM
PHASE 3 EXPLORER-HCM TRIAL
Source text for Eikon: ID:nGNX4fQBtJ
Further company coverage: LIAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LianBio
See all newsChina's Zeekr prices US IPO at top of range to raise $441 million (updated)
U.S. STOCKS ON THE MOVE-JetBlue Airways, LPL Financial, Nvidia
U.S. STOCKS ON THE MOVE-Bicycle Therapeutics, Molson Coors, LianBio
LianBio completes strategic review, cuts jobs; shares up
Brief: LianBio Announces Completion Of Strategic Review